See more : Hyve Group Plc (ITEPF) Income Statement Analysis – Financial Results
Complete financial analysis of HEXO Corp. (HEXO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HEXO Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- GREE, Inc. (3632.T) Income Statement Analysis – Financial Results
- Angel Fibers Limited (ANGEL.BO) Income Statement Analysis – Financial Results
- Flughafen Wien Aktiengesellschaft (FGWLF) Income Statement Analysis – Financial Results
- Macroblock, Inc. (3527.TWO) Income Statement Analysis – Financial Results
- Brite-Strike Tactical Illumination Products, Inc. (BSTK) Income Statement Analysis – Financial Results
HEXO Corp. (HEXO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hexocorp.com
About HEXO Corp.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 191.10M | 123.77M | 80.78M | 47.54M | 4.93M | 4.10M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 266.78M | 74.97M | 138.76M | 20.62M | -1.47M | -2.35M | 0.00 | 0.00 | 0.00 |
| Gross Profit | -75.67M | 48.80M | -57.98M | 26.93M | 6.40M | 6.45M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -39.60% | 39.43% | -71.77% | 56.64% | 129.72% | 157.39% | 0.00% | 0.00% | 0.00% |
| Research & Development | 3.22M | 3.84M | 4.64M | 2.82M | 0.00 | 86.38K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 99.31M | 69.92M | 78.58M | 73.96M | 14.37M | 4.27M | 0.00 | 29.29K | 29.29K |
| Selling & Marketing | 22.93M | 10.35M | 12.47M | 31.19M | 8.34M | 2.99M | 0.00 | 0.00 | 0.00 |
| SG&A | 122.24M | 80.27M | 91.06M | 105.15M | 22.71M | 7.25M | 0.00 | 29.29K | 29.29K |
| Other Expenses | 28.78M | 8.15M | 322.88M | 3.51M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 154.24M | 92.25M | 418.58M | 111.48M | 24.37M | 7.93M | 0.00 | 29.29K | 29.29K |
| Cost & Expenses | 421.01M | 167.22M | 557.34M | 132.10M | 22.90M | 5.58M | 0.00 | 29.29K | 29.29K |
| Interest Income | 1.65M | 1.60M | 1.90M | 5.19M | 2.12M | 92.16K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 20.07M | 32.12M | 10.04M | 469.00K | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 810.10M | 16.73M | 68.25M | 5.85M | 1.66M | 591.65K | 22.82K | 0.00 | 0.00 |
| EBITDA | -257.63M | -26.73M | -476.55M | -78.70M | -14.19M | -1.75M | 0.00 | -29.29K | -29.29K |
| EBITDA Ratio | -134.81% | -21.59% | -589.91% | -165.55% | -287.60% | -42.73% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.07B | -43.45M | -476.55M | -84.56M | -17.97M | -1.48M | 0.00 | -29.29K | -29.29K |
| Operating Income Ratio | -558.72% | -35.11% | -589.91% | -177.86% | -364.14% | -36.21% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -691.53M | -71.71M | -75.96M | -847.00K | -5.38M | -10.93M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -1.11B | -115.16M | -552.51M | -85.40M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Income Before Tax Ratio | -582.11% | -93.04% | -683.94% | -179.64% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.81M | -397.00K | -6.02M | -3.84M | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Net Income | -1.07B | -114.76M | -546.49M | -81.56M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Net Income Ratio | -561.80% | -92.72% | -676.48% | -171.57% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| EPS | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| EPS Diluted | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| Weighted Avg Shares Out | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
| Weighted Avg Shares Out (Dil) | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
HEXO Corp. annonce le dépôt d’un supplément à la circulaire de sollicitation de procurations pour la nomination de l’auditeur
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX : HEXO; NASDAQ : HEXO) (« HEXO » ou la « Société »), producteur majeur de produits de cannabis de haute qualité, a annoncé aujourd’hui qu’elle a déposé des documents modifiés relatifs à l’assemblée (collectivement,...
HEXO Corp. Announces Filing of Supplement to Proxy Circular for Appointment of Auditor
GATINEAU, Quebec--( BUSINESS WIRE )--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, today announced that it has filed amended meeting materials (collectively, the “Amended Meeting Materials”) consisting of an amended notice...
HEXO Corp. Announces Filing of Supplement to Proxy Circular for Appointment of Auditor
GATINEAU, Quebec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, today announced that it has filed amended meeting materials (collectively, the “Amended Meeting Materials”) consisting of an amended notice of meeting...
HEXO annonce le lancement de cinq nouvelles variétés de cannabis sous les marques de renom Redecan et Original Stash
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp (TSX : HEXO ; NASDAQ : HEXO) (« HEXO » ou la « Société »), un important producteur de produits de cannabis de haute qualité, est heureuse d’annoncer le lancement de ses nouvelles souches de cannabis...
HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash Brands
GATINEAU, Quebec--( BUSINESS WIRE )--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, is pleased to announce the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brands...
HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash Brands
GATINEAU, Quebec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, is pleased to announce the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brands labels across...
Why Are Cannabis Stocks TLRY, ACB, HEXO Down Today?
Cannabis stocks are falling today on news that new regulation may be looming in 2023. Recent reports indicate the Food and Drug Administration (FDA) is planning a review of hemp-derived products including cannabidiol (CBD).
What Is Going On With HEXO Stock Today?
Hexo (NASDAQ: HEXO ) stock is trending on social media after the company announced that it would carry out a “consolidation” of its shares that are listed in New York and of its stock that trades in Canada. The announcement,...
HEXO (HEXO) Reports Q1 Loss, Misses Revenue Estimates
HEXO (HEXO) delivered earnings and revenue surprises of -250% and 19.23%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
HEXO Reports Q1'23 Financial Results
This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021.
Source: https://incomestatements.info
Category: Stock Reports